North America represents a major regional market for allergic rhinitis, driven by growing allergy incidence, strong healthcare spending, and increasing adoption of advanced diagnostic and treatment solutions. The presence of leading pharmaceutical companies, favorable reimbursement systems, and ongoing research into innovative therapies continue to strengthen the region's market growth through...